APH vs IMA · P/E 40, rev $23.09B vs rev $9.2M
Amphenol Corporation (APH) versus ImageneBio, Inc. (IMA) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
APH currently screens at market cap $170.77B and trailing P/E 39.9. IMA currently screens at market cap $64.7M.
Not investment advice. Open the APH and IMA stock pages for the full models.
Not investment advice.